Results of a United Kingdom real-world study of polatuzumab vedotin, bendamustine, and rituximab for relapsed/refractory DLBCLMichael Northend, William Townsend, Andrew Davies et al.|Blood Advances|2022Cited by 44
Progressing gender equality in fisheries by building strategic partnerships with development organisationsSangeeta Mangubhai, Meryl J. Williams, Sarah Lawless et al.|World Development|2022Cited by 28